Table 3.
Study or subgroup | Etoricoxib |
Diclofenac |
Weight | Peto OR, Fixed, 95% CI | ||
---|---|---|---|---|---|---|
Events | Total | Events | Total | |||
EDGE 2005 [Baraf et al. 2007] | 19 | 3593 | 13 | 3518 | 47.2% | 1.43 [0.71, 2.86] |
EDGE II [Kreuger et al. 2008] | 14 | 2032 | 22 | 2054 | 52.8% | 0.65 [0.34, 1.24] |
Total (95% CI) | 5625 | 5572 | 100.00% | 0.94 [0.58, 1.51] | ||
Total events | 33 | 35 |
Heterogeneity: chi squared = 2.65, degrees of freedom = 1 (p = 0.10); I2 = 62%. Test for overall effect: Z = 0.26 (p = 0.79).
CI, confidence interval; OR, odds ratio.